Marex Investors Face Dec. 8 Lead-Plaintiff Deadline in SDNY Securities Suit

Overview

• Narayanan v. Marex Group PLC, No. 25-cv-08393, is pending in the Southern District of New York.
• The putative class covers purchases from May 16, 2024 through August 5, 2025, with a December 8, 2025 deadline to seek lead-plaintiff status.
• The complaint alleges self-dealing in over-the-counter instruments, discrepancies in intercompany receivables and loans, unreliable financial statements, and inflated cash flow and Market Making results through off-book intercompany transactions.
• An August 5, 2025 NINGI Research report cited off-balance-sheet entities, a $17 million receivable, and nearly $1 billion in derivatives exposure, after which Marex shares fell 6.2% to $35.31 on heavy volume.
• Multiple plaintiff firms and services are soliciting investors, no class has been certified, and notices state that the allegations have not been proven.